Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis

Gut

Volumn 42, Issue 5, 1998, Pages 721-726

  Muratori, L ^a,b   Cataleta, M ^a   Muratori, P ^a   Lenzi, M ^a   Bianchi, F B ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autoantibodies; Immunoblotting; Immunosuppression; LC1; LKM1

Indexed keywords

ALANINE AMINOTRANSFERASE; AUTOANTIBODY; AUTOANTIGEN; AZATHIOPRINE; CYTOCHROME P450 ISOENZYME; MICROSOME ANTIBODY; POLYPEPTIDE; STEROID;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CHEMOLUMINESCENCE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COUNTER IMMUNOELECTROPHORESIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY MICROSOME; LIVER CYTOSOL; LIVER MICROSOME; LIVER NECROSIS; MALE; PRIORITY JOURNAL;

EID: 0031839605     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.5.721     Document Type: Article

References (29)

1. Czaja AJ. Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci 1995;40:435-56.
2. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996;334:897-903.
3. Maggiore G, Bernard O, Homberg JC, et al. Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr 1986;108:399-404.
4. Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987;7:1333-9.
5. Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 1995;90:1206-11.
6. Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-7.
7. Martini E, Abuaf N, Cavalli F, et al. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988;8:1662-6.
8. Manns MP. Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance. Semin Liver Dis 1991;11:205-14.
9. Yamamoto AM, Cresteil D, Boniface O, et al. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1). Eur J Immunol 1993;23:1105-11.
10. Muratori L, Lenzi M, Ma Y, et al. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 1995;37:406-12.
11. Loeper J, Descatoire V, Maurice M, et al. Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology 1993;104: 203-16.
12. Yamamoto AM, Mura C, De Lemos-Chiarandini C, et al. Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes. Clin Exp Immunol 1993;92:381-90.
13. Vergani D, Mieli-Vergani G. Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6. Clin Exp Immunol 1993;92:367-8.
14. Abuaf N, Johanet C, Chretien P, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatoogy 1992;16:892-8.
15. Lenzi M, Manotti P, Muratori L, et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut 1995;36:749-54.
16. Han S, Tredger M, Gregorio GV, et al. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology 1995;21:58-62.
17. Muratori L, Cataleta M, Muratori P, et al. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques. J Immunol Methods 1995;187:259-64.
18. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
19. Zanger UM, Hauri HP, Loeper J, et al. Antibodies against human cytochrome P450-db1 in autoimmune hepatitis type II. Proc Natl Acad Sci USA 1988;85:8256-60.
20. Abuaf N, Johanet C, Soulie E, et al. Anti-liver cytosol antibodies in hepatology: autoimmune hepatitis, viral hepatitis C and graft-versus-host disease. In: Meyer zum Büschenfelde KH, Hoofnagle JH, Manns M, eds. Immunology and liver Falk Symposium 70. London: Kluwer Academic Publishers, 1993:215-26.
21. Ma Y, Gregorio CJ, Gäken J, et al. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection. J Hepatol 1997;26: 1396-402.
22. Joplin R, Gordon Lindsay J, Johnson GD, et al. Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. Lancet 1992; 339:93-4.
23. Koren E, Wolfson A, Koscec M, et al. Autoantibodies to ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992;89:1236-41.
24. Hopf U, Meyer zum Büschenfelde KH, Arnold W. Detection of a liver membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med 1976;294: 578-82.
25. Swanson NR, Reed WD, Yarred LJ, et al. Autoantibodies to isolated human hepatocyte plasma membranes in chronic active hepatitis. II. Specificity of antibodies. Hepatology 1990;11:613-21.
26. Toda G, Ikeda Y, Kashigawi M, et al. Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis: its identification as sulfatide. Hepatology 1990;12:664-70.
27. Meyer zum Büschenfelde KH, Miescher PA. Liver-specific antigens, purification and characterization. Clin Exp Immunol 1972;10:89-102.
28. McFarlane IG, McFarlane BM, Major GN, et al. Identification of the hepatic asialoglycoprotein receptor (hepatic lectin) as a component of liver-specific membrane lipoprotein (LSP). Clin Exp Immunol 1984;55:347-54.
29. McFarlane BM. Hepatocellular membrane antigens. In. McFarlane IG, Williams R, eds. Medical Intelligence Unit. Molecular basis of autoimmune hepatitis. Austin: RG Landes Company, 1996:75-104.